Who is sponsoring NCT05615831?

NCT05615831 is sponsored by University of New Brunswick.

What drugs are being tested in NCT05615831?

Interventions in NCT05615831: Resistance Training with Blood flow restriction.

What condition does NCT05615831 study?

NCT05615831 studies Physical Activity.

Is NCT05615831 still recruiting?

NCT05615831 is currently completed. Last updated 13 December 2023.

Last reviewed 2023-12-13 · How we verify

NCT05615831

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Exercise With Blood Flow Restriction: Sex and Age Differences

Completed NA Last updated 13 December 2023

What this trial tests

NA trial testing Resistance Training with Blood flow restriction in Physical Activity in 72 participants. Completed in 22 November 2023.

Timeline

1 May 2022

Primary endpoint
22 November 2023

22 November 2023

Quick facts

Lead sponsor	University of New Brunswick
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	72
Start date	1 May 2022
Primary completion	22 November 2023
Estimated completion	22 November 2023
Sites	1 location across Canada

Drugs / interventions tested

Resistance Training with Blood flow restriction

Conditions studied

Physical Activity — all drugs for Physical Activity →

Sponsor

University of New Brunswick

Who can join

Adults 19 to 100, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to investigate whether six weeks of resistance training, in combination with blood flow restriction, produces a different adaptation in fat-free mass between males and females that are not physically active. The secondary objective is to compare changes in physical function, physical performance, and blood biomarkers between males and females following resistance training and blood flow restriction.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of exercise with blood flow restriction on muscle hypertrophy and performance outcomes in men and women.
Nancekievill D, Seaman K, Bouchard DR, Thomson AM, et al · · 2025 · cited 5× · PMID 39874353 · DOI 10.1371/journal.pone.0301164
Age-Related Differences in Adaptation of Lean Body Mass, Muscle Strength, and Performance Following 6 Weeks of Blood Flow Restriction Training in Young and Older Adults.
Arnason JK, Thomson AM, Peskett LE, Nancekievill DA, et al · · 2025 · cited 2× · PMID 40035085 · DOI 10.22540/jfsf-10-037
Impact of blood flow restriction training timing: Does exercising at dusk or dawn enhance response?
Peskett LE, Thomson AM, Rioux BV, Nancekievill D, et al · · 2025 · cited 1× · PMID 41189465 · DOI 10.14814/phy2.70644

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting

Other University of New Brunswick trials

Trials by the same sponsor.

NCT07309536 — Mediterranean Diet Uptake and Nutrition on Child Health, Inflammation, and Early-life Symbiosis (MUNCHIES) Study · NA · not yet recruiting
NCT06285786 — Patient Handling Techniques and New Technology for Health Care Workers · NA · unknown
NCT05385458 — Acceptance and Commitment Therapy (ACT) Tele-Counselling · NA · completed
NCT04997681 — SYNchronizing Exercises, Remedies in Gait and Cognition at Home (SYNERGIC@Home) · NA · completed
NCT06462534 — The Band-Frail Study: A Provincial Intervention to Outweigh Diabetes and Frailty in New Brunswick · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05615831 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of New Brunswick
Last refreshed: 13 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05615831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing